Literature DB >> 2885639

Ultrafiltration with an isosmotic solution during long peritoneal dialysis exchanges.

C D Mistry, N P Mallick, R Gokal.   

Abstract

The potential of a starch-derived glucose polymer (molecular weight 16,800) as an osmotic agent for peritoneal dialysis was evaluated. A dialysate isosmotic to uraemic serum (302 [SEM 1.3] mOsm/kg) containing 5% glucose polymer (9.4 mmol/l) was compared with hypertonic (332 [1.0] mOsm/kg) 1.36% glucose (76 mmol/l) solution for ultrafiltration, solute transport, and carbohydrate absorption over 6 h and 12 h peritoneal dialysis exchanges. Glucose polymer solution produced substantially greater net ultrafiltration than glucose, while maintaining stable dialysate osmolality throughout the exchanges. At 6 h and 12 h, 14.4% and 28.1% of glucose polymer had been absorbed, compared with 61.5% and 83.0% of glucose; thus, glucose polymer provided less than 50% of the calorie load of the glucose dialysate per unit volume of ultrafiltrate. There was a 7-9-fold increase in serum maltose with glucose polymer. This high-molecular-weight glucose polymer produced sustained ultrafiltration even when dialysate osmolality remained within the physiological range, by a mechanism resembling "colloid" osmosis. It is a safe and effective osmotic agent but its long-term effects need further study.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2885639     DOI: 10.1016/s0140-6736(87)90764-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

1.  Intraperitoneal IL-6 signaling in incident patients treated with icodextrin and glucose bicarbonate/lactate-based peritoneal dialysis solutions.

Authors:  Sylvie Opatrna; Daniel Lysak; Ladislav Trefil; Clare Parker; Nicholas Topley
Journal:  Perit Dial Int       Date:  2012 Jan-Feb       Impact factor: 1.756

2.  Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial.

Authors:  Yuji Takatori; Shigeru Akagi; Hitoshi Sugiyama; Junko Inoue; Shoichiro Kojo; Hiroshi Morinaga; Kazushi Nakao; Jun Wada; Hirofumi Makino
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 8.237

Review 3.  Peritoneal damage by peritoneal dialysis solutions.

Authors:  Takafumi Ito; Noriaki Yorioka
Journal:  Clin Exp Nephrol       Date:  2008-02-15       Impact factor: 2.801

Review 4.  Encapsulating peritoneal sclerosis: the state of affairs.

Authors:  Mario R Korte; Denise E Sampimon; Michiel G H Betjes; Raymond T Krediet
Journal:  Nat Rev Nephrol       Date:  2011-08-02       Impact factor: 28.314

5.  Use of icodextrin 4% solution in the prevention of adhesion formation following general surgery: from the multicentre ARIEL Registry.

Authors:  D Menzies; M Hidalgo Pascual; M K Walz; J J Duron; F Tonelli; A Crowe; A Knight
Journal:  Ann R Coll Surg Engl       Date:  2006-07       Impact factor: 1.891

6.  Mechanisms of Crystalloid versus Colloid Osmosis across the Peritoneal Membrane.

Authors:  Johann Morelle; Amadou Sow; Charles-André Fustin; Catherine Fillée; Elvia Garcia-Lopez; Bengt Lindholm; Eric Goffin; Fréderic Vandemaele; Bengt Rippe; Carl M Öberg; Olivier Devuyst
Journal:  J Am Soc Nephrol       Date:  2018-05-29       Impact factor: 10.121

7.  A patient with refractory nephrotic syndrome withdrawn from peritoneal dialysis.

Authors:  Satoshi Morimoto; Nobuyuki Takahashi; Kazunori Someya; Tatsuyori Morita; Fusakazu Jo; Nagaoki Toyoda; Atsushi Kosaki; Mitsushige Nishikawa; Toshiji Iwasaka
Journal:  Clin Exp Nephrol       Date:  2010-02-26       Impact factor: 2.801

Review 8.  Icodextrin: a review of its use in peritoneal dialysis.

Authors:  James E Frampton; Greg L Plosker
Journal:  Drugs       Date:  2003       Impact factor: 9.546

9.  Molecular weight of polydisperse icodextrin effects its oncotic contribution to water transport.

Authors:  Kohei Nishimura; Yohei Kamiya; Keiichi Miyamoto; Shinsuke Nomura; Takashi Horiuchi
Journal:  J Artif Organs       Date:  2008-10-05       Impact factor: 1.731

10.  Pharmacokinetic study of 5-fluorouracil in a novel dialysate solution: a long-term intraperitoneal treatment approach for advanced colorectal carcinoma.

Authors:  C S McArdle; D J Kerr; P O'Gorman; H A Wotherspoon; H Warren; D Watson; B J Vinké; J W Dobbie; D I el Eini
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.